Levels of five biomarker candidates for HCC were higher in stage III and IV than in stage I and II and levels of fibrinogen gamma chain and selenoprotein P changed in metastatic HCC (S2 Fig). The gene discussed is SELENOP; the disease is hepatocellular carcinoma.